Can Cannabis Interact with Other Medications? Understanding the Risks

Yes. Cannabis and CBD products can interact with medications, but the evidence and consequences differ by drug, cannabinoid dose, and formulation. Some combinations have documented clinical interactions; others raise plausible concerns that have not been adequately tested in people. A pharmacist or prescriber should review your actual medication list and cannabis product.

How Interactions Can Happen

Interactions can change drug concentrations or combine effects such as sedation. CBD is not intoxicating in the same way as THC, but it is not interaction-free. Evidence from prescription cannabidiol cannot automatically predict the size of an interaction with a low-dose retail gummy, smoked cannabis, or a topical product.

The FDA prescribing information for Epidiolex, a purified cannabidiol medicine, documents drug interactions and warns that other central nervous system depressants, including alcohol, may increase sedation. Feeling no “high” does not establish that a CBD product is compatible with your medicines.

Five Common OTC Medication Categories

Acetaminophen: Tylenol and Combination Products

Acetaminophen can cause serious liver damage when too much is taken. Check cold, flu, and pain remedies for duplicate ingredients and follow their dosing instructions. The fact that two substances are processed by the liver does not, by itself, establish a harmful interaction.

Prescription CBD can also cause liver injury, but the size of any added risk with acetaminophen is not established. The Epidiolex label notes insufficient data for combinations with other liver-toxic drugs beyond the interactions it specifically describes. Discuss liver disease, regular acetaminophen use, and CBD with a clinician rather than assuming the combination is either proven dangerous or proven safe.

Ibuprofen: Advil and Motrin

Ibuprofen has established gastrointestinal bleeding, kidney, and cardiovascular risks. These require attention regardless of cannabis use. There is not a sound basis here to recommend cannabis as a proven way to improve ibuprofen’s pain relief or to prescribe a special lower ibuprofen dose for the combination. Ask a pharmacist to assess your other medicines, particularly anticoagulants and other NSAIDs.

Aspirin

Aspirin affects platelets and can cause bleeding. Do not assume that THC has a predictable additional “blood-thinning” effect or apply warfarin interaction findings directly to aspirin. If you take prescribed aspirin, do not stop it or alter the dose on your own. A clinician should review cannabis use alongside your reason for taking aspirin and other bleeding risks.

Antihistamines: Benadryl and Claritin

Diphenhydramine, sold as Benadryl, can cause drowsiness. Combining impairing or sedating products deserves particular caution. Loratadine, sold as Claritin, belongs among the antihistamines that cause less sleepiness; it should not be described as equally sedating. Individual reactions still vary. Do not drive while impaired, and check sleep aids and combination cold products for sedating ingredients.

Pseudoephedrine: Sudafed

Pseudoephedrine requires precautions in people with high blood pressure or heart disease and can cause nervousness or sleep difficulty. A concern about combining its effects with THC is a reason for individualized review, not a well-established numerical interaction risk. Report your cardiovascular history and all medicines to a pharmacist before choosing a decongestant.

Prescription Interactions With Clinical Evidence

• Clobazam: Prescription CBD increased exposure to clobazam’s active metabolite approximately threefold in interaction studies. Prescribers may need to adjust treatment if adverse effects occur.
• Valproate: Combining it with prescription CBD increases the incidence of liver enzyme elevations. This risk does not require a rise in valproate concentration.
• Tacrolimus: A phase I study in 12 healthy participants found approximately 3.1-fold greater total tacrolimus exposure with CBD at 5 mg/kg twice daily. Transplant patients should involve their transplant team; blood-level monitoring and clinician-directed adjustments may be needed.
• Warfarin: A systematic review identified seven case reports, with increased INR in six. This is limited evidence, but it supports notifying the anticoagulation team when starting, stopping, or changing cannabis or CBD. It does not establish identical interactions with every anticoagulant.

Make the Medication Review Specific

Bring the product label, THC and CBD amounts, route of use, frequency, and any recent changes. Include prescriptions, OTC medicines, supplements, alcohol, and sleep aids. Ask whether the combination should be avoided, whether laboratory monitoring is needed, and which symptoms require help.

Do not adjust essential medication based on a general interaction list. The safest next step is a review of the exact combination, with a clear monitoring plan when appropriate.